CJC/Ipamorelin combines two research peptides studied for their interaction with growth-hormone-related signalling pathways. CJC is a GHRH-related research peptide, while Ipamorelin interacts with the ghrelin receptor. Researchers investigate these compounds to better understand growth hormone release, endocrine signalling and downstream biological pathways associated with growth hormone and IGF-1. For research purposes only.